Results

PharmaEssentia Corporation

04/27/2022 | Press release | Distributed by Public on 04/27/2022 03:34

Announcement of Marketing Authorization Applicati- on Submission of Ropeginterferon alfa-2b for PV in Japan on Behalf of Subsidiary PharmaEssentia Japan KK.